---
category: disclosure
circular_id: 0389556fde155427
date: '2026-02-25'
description: BSE surveillance clarifications from Lippi Systems Limited, Aegis Logistics
  Ltd, and Bacil Pharma Ltd regarding unusual price and volume movements in their
  equity shares.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={68CFD74B-0E5A-47E7-A2D6-11BC56A98788}&noticeno=20260225-39&dt=02/25/2026&icount=39&totcount=42&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine surveillance clarification letters from three companies denying
  possession of any unpublished price sensitive information; no material disclosures
  or regulatory changes involved.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260225-39&attachedId=d5cfede2-164e-427f-a85d-67120e09b9f1
processing:
  attempts: 1
  content_hash: 01b8585ae59b7236
  processed_at: '2026-02-25T16:14:48.769875'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-25T15:07:36+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={68CFD74B-0E5A-47E7-A2D6-11BC56A98788}&noticeno=20260225-39&dt=02/25/2026&icount=39&totcount=42&flag=0
severity: low
source: bse
stocks:
- LIPPI
- AEGISLOG
- BACILPHARMA
tags:
- surveillance
- price-movement
- volume-movement
- clarification
- sebi-lodr
- disclosure
- compliance
- lippi-systems
- aegis-logistics
- bacil-pharma
title: Clarifications Received from Companies on Price/Volume Movement
---

## Summary

BSE received clarification letters from three listed companies — Lippi Systems Limited (Scrip Code: 526604), Aegis Logistics Ltd (Scrip Code: 500003), and Bacil Pharma Ltd (Scrip Code: 524516) — in response to BSE Online Surveillance queries regarding unusual price or volume movement in their respective equity shares. All three companies have affirmed compliance with SEBI (LODR) Regulations, 2015 and denied possession of any undisclosed price-sensitive information.

## Key Points

- Lippi Systems Limited responded to BSE surveillance email ref. L/SURV/ONL/PV/SJ/2025-2026/3396 dated 24 February 2026, stating no material information has been withheld and that price movement is purely market-driven.
- Aegis Logistics Ltd responded to BSE surveillance email ref. L/SURV/ONL/PV/SG/2025-2026/936 dated 25 February 2026, attributing volume increase to investor interest based on company performance/prospects.
- Bacil Pharma Ltd responded to BSE surveillance letter ref. L/SURV/ONL/PV/SJ/2025-2026/3393 dated 24 February 2026, stating no unpublished price sensitive information or material development is in their possession.
- All three companies affirm ongoing compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
- No specific reason for price/volume movement has been identified by any of the companies.

## Regulatory Changes

No regulatory changes. These are standard responses to BSE surveillance queries under the existing SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 framework.

## Compliance Requirements

- Companies reaffirm adherence to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding timely disclosure of material events and information.
- All three companies confirm they will continue to promptly inform stock exchanges of any material developments as and when they occur.

## Important Dates

- 24 February 2026: BSE surveillance queries issued to Lippi Systems Limited (ref. 3396) and Bacil Pharma Ltd (ref. 3393).
- 25 February 2026: BSE surveillance query issued to Aegis Logistics Ltd (ref. 936).
- 25 February 2026: Clarification letters submitted by all three companies.

## Impact Assessment

Low market impact. These are routine surveillance compliance responses with no material disclosures. The clarifications confirm no undisclosed price-sensitive information exists at the respective companies. Investors should note that price/volume movements in LIPPI (526604), AEGISLOG (500003), and BACILPHARMA (524516) have been attributed to market-driven factors with no company-specific catalyst identified.